The dm1ACRISPR system can upregulate the expression of ATP5D through targeted removal of ATP5D m1A modification, resulting in an increase in the level of glycolysis of tumor cells (Wu et al., 2022). This evidence concerns the gene ATP5F1D and neoplasm.